Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
American Journal of Hematology|August 7, 2023
Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine-A prospective cohort study by the AGMTLisa Pleyer, Marc Vaisband, Manuel Drost, et al.American Journal of Hematology|February 23, 2023
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasmsDaniel Ivanov, Jelena D Milosevic Feenstra, Irina Sadovnik, et al.European Journal of Haematology|May 17, 2021
Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemiaSigrid Machherndl-Spandl, Eva Jäger, Agnes Barna, et al.Genes, Chromosomes & Cancer|September 11, 2015
Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control groupFriederike Braulke, Catharina Müller-Thomas, Katharina Götze, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 9, 2025
A proposed path to explaining the unexplained anemia of agingNahed El Kassar, Amy E DeZern, Janis Abkowitz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database mergeJulie Schanz, Heinz Tüchler, Francesc Solé, et al.International Journal of Molecular Sciences|February 18, 2017
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study GroupLisa Pleyer, Hartmut Döhner, Hervé Dombret, et al.International Journal of Molecular Sciences|April 30, 2020
Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 PatientsKlaus Geissler, Eva Jäger, Agnes Barna, et al.Haematologica|October 26, 2014
Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control groupFriederike Braulke, Uwe Platzbecker, Catharina Müller-Thomas, et al.Oncotarget|November 2, 2017
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditionsPeter Valent, Attilio Orazi, David P Steensma, et al.Pageof 6